Evidence map›Paper›PMID 40864714›Full record

ArticleScience advances2025

Annotation-free discovery of disease-relevant cells in single-cell datasets.

Erin Craig, Timothy J Keyes, Jolanda Sarno, Jeremy P D'Silva, Pablo Domizi, Maxim Zaslavsky, Albert Tsai, David Glass, Garry P Nolan, Trevor Hastie and 2 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Erin CraigDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID 0000-0002-4893-6671
Timothy J KeyesDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID 0000-0003-0423-9679
Jolanda SarnoDivision of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.ORCID 0000-0003-3488-0248
Jeremy P D'SilvaDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID 0009-0005-0053-7726
Pablo DomiziDivision of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.ORCID 0000-0003-2903-0337
Maxim ZaslavskyDepartment of Genetics, Stanford University, Stanford, CA, USA.ORCID 0000-0003-4300-7854
Albert TsaiDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-6607-3347
David GlassVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0001-9924-167X
Garry P NolanDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-8862-9043
Trevor HastieDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID 0000-0002-0164-3142
Robert TibshiraniDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID 0000-0003-0553-5090
Kara L DavisDivision of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.ORCID 0000-0002-7182-2592

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NOLAN, GARRY P · 2012 to 2021
$49.1M
Spatial-Genomic Integrative Multi-Species Analysis of Lymph Node MetastasisU54CA209971 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P, PLEVRITIS, SYLVIA KATINA · 2016 to 2021
$11.0M
New Statistical Methods for Medical Signals and ImagesR01EB001988 · NIBIB · STANFORD UNIVERSITY · PI JOHNSTONE, IAIN M · 2003 to 2018
$6.1M
New Statistical Methods for Medical Signals and ImagesR01GM134483 · NIGMS · STANFORD UNIVERSITY · PI Iain M Johnstone · 2019 to 2026
$3.9M
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic LeukemiaR01CA251858 · NCI · STANFORD UNIVERSITY · PI DAVIS, KARA LYNN · 2021 to 2025
$3.1M
Predicting Post-treatment Relapse in Pediatric Acute Myeloid Leukemia Using Single-cell ProteomicsF31CA239365 · NCI · STANFORD UNIVERSITY · PI KEYES, TIMOTHY JAMES · 2019 to 2020
$78k
NCI NIH HHS F31 CA239365NCI NIH HHS R01 CA251858NCI NIH HHS U54 CA209971NIAID NIH HHS U19 AI100627NIBIB NIH HHS R01 EB001988NIGMS NIH HHS R01 GM134483
6 · The paper itself

Abstract

In single-cell datasets, patient labels indicating disease status (e.g., "sick" or "not sick") are typically available, but individual cell labels indicating which of a patient's cells are associated with their disease state are generally unknown. To address this, we introduce mixture modeling for multiple-instance learning (MMIL), an expectation-maximization approach that trains cell-level binary classifiers using only patient-level labels. Applied to primary samples from patients with acute leukemia, MMIL accurately separates leukemia from nonleukemia baseline cells, including rare minimal residual disease (MRD) cells; generalizes across tissues and treatment time points; and identifies biologically relevant features with accuracy approaching that of a hematopathologist. MMIL can also incorporate cell labels when they are available, creating a robust framework for leveraging both labeled and unlabeled cells. MMIL provides a flexible modeling framework for cell classification, especially in scenarios with unknown gold-standard cell labels.

Indexed as

LeukemiaSingle-Cell AnalysisAlgorithmsHumansNeoplasm, Residual

Identifiers

PMID40864714
PMCPMC12383263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.